Indaptus Therapeutics Inc (INDP) — Cash Flow Reinvestment Rate
Latest as of September 2020:
0.17x
Indaptus Therapeutics Inc (INDP) has a Cash Flow Reinvestment Rate of 0.17x as of September 2020, reinvesting $772.00K (capex $3.00K plus investments $-769.00K) from operating cash flow of $4.45 Million. Check Indaptus Therapeutics Inc (INDP) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
0.17x
(Capex + Investments) / Operating CF
Total Reinvested
$772.00K
Capex + Investments
Operating Cash Flow
$4.45 Million
USD
Capital Expenditures
$3.00K
USD
Annual Cash Flow Reinvestment Rate for Indaptus Therapeutics Inc (None–None)
Year-by-year capital reinvestment analysis for Indaptus Therapeutics Inc. For live market cap and broader valuation context, see market value of Indaptus Therapeutics Inc.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow